Beijing Chunlizhengda Medical Instruments Co Ltd 2020 AR2
The report highlights Beijing Chunlizhengda Medical Instruments Co., Ltd.'s financial and ESG performance for the fiscal year 2020. The company recorded a revenue of approximately RMB 937.7 million, representing a year-on-year increase of 9.63%, and a net profit of RMB 283.4 million. Key achievements included the launch of the BIOLOX®OPTION ceramic head product with cone sleeve and the spinal fusion device, as well as the introduction of the handheld orthopedic robot system 'Yangtze River INS'. On the ESG front, the company implemented dust removal equipment to eliminate over 98% of dust, established sewage treatment stations, and continued its 'Chunli Sunshine Plan' medical charity project.
Company: Beijing Chunlizhengda Medical Instruments Co Ltd
Sector: Manufacturing
Country: China
Year: 2020
Type: AR2
Pages: 141
Beijing Chunlizhengda Medical Instruments Co Ltd
The report highlights Beijing Chunlizhengda Medical Instruments Co., Ltd.'s financial and ESG performance for the fiscal year 2020. The company recorded a revenue of approximately RMB 937.7 million, representing a year-on-year increase of 9.63%, and a net profit of RMB 283.4 million. Key achievements included the launch of the BIOLOX®OPTION ceramic head product with cone sleeve and the spinal fusion device, as well as the introduction of the handheld orthopedic robot system 'Yangtze River INS'. On the ESG front, the company implemented dust removal equipment to eliminate over 98% of dust, established sewage treatment stations, and continued its 'Chunli Sunshine Plan' medical charity project.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Workplace Fatalities
Employees